Main Menu          To Health Library            Antioxidants a Global Analysis

 

VITAMIN C and CANCER

Abstract:  Results from 29 study comparison sets found show that Vitamin C in average amounts of about 400 mg. per day may reduce risk of most types of cancer by about by 23% after 10 -15 or more years of its use.   Benefits appear indicated up to about 750 mg per day of the Vitamin in the total of both foods plus supplements.  Because a usual amount in food will be only about 200-250 mg per day, and Vitamin C also reduces risk of heart disease, use of a daily supplement of 500 mg of Vitamin C would appear prudent for most health-interested men and women.

Vitamin C has been widely publicized as an agent to reduce risk of heart disease.  But research now shows that as an antioxidant it also appears to reduce risk of cancer similarly.  See the discussion on Vitamin C and Heart Disease for more about Vitamin C.

Results for 29 comparisons in 23 studies of Vitamin C in reducing risks of cancer in the table following provide a average risk benefit of about 0.77 or risk reduction of 23%.  24 of the comparisons showed benefits for Vitamin C;  5 found no benefit and possible reasons for those that found no benefits are suggested.  The Nurse's study found no benefit in studies #1 and 6 for its younger than usual group of women, similar to their results found for other antioxidant vitamins and selenium. The nurses averaged much younger than did participants of the other studies, and many were pre-menopausal. Also the nurses appear to have used appreciably more other antioxidant supplements in their diets than did other groups. This average result is for typical differences of about 400 mg per day of Vitamin C from diet plus supplements. Larger amounts of the vitamin should produce somewhat large benefits.

The table following lists the number of study comparisons found for each type of cancer and average for all comparisons.  Benefits are  noted for each type of cancer, the risks probably all are statistically consistent with the average risk factor of 0.77 for the 23 comparisons.  No useful randomized clinical study results were found for Vitamin C but it is unlikely that such a study done for less than 10-15 years would be able to measure usefully a correct long range effect of this or any other antioxidant.  Similar risks were indicated for the various types of cancer, but results did not have the accuracy to identify specific differences.  Most benefits for Vitamin C were measured from diets of foods.

    Effect of Vitamin C in Reducing Risk of Types of Cancer
  Cancer Site  Number of   Comparisons      Avg Risk Ratio
 Breast 6 0.79
 Prostate 3 0.69
 Ovarian & Cervical 5 0.77
 Colorectal 1 0.94
 Throat and Oral 1 0.63
 Gastric 4 0.74
 Stomach 1 0.83
 All Cancer 2 0.74
          Total 23 0.77

As for its effect on heart disease, Vitamin C probably acts to reduce the rate of cancer development, and this will reduce risk at a modest value for each year of use.  Life Ahead now uses a risk value for cancer of about 0.983 per year of exposure for a difference of 400 mg per day of Vitamin C from diet plus supplements up to a maximum duration of 20 years.  This produces a risk reduction of about 25% after 20 years.   The risks of cancer from Vitamin C are the same as those for the vitamin in reducing risks of cardiovascular disease.  Thus the same formula will apply for both risks.  This formula follow the table of results. Some values from the formula are in the following table:

Risk Ratios of Cancer from Amount and Duration of Vitamin C

Duration of use

in Years

1

5

10

20

 Vitamin C in mg

 

 

 

 

100

0.990

0.98

0.91

0.83

200

0.986

0.94

0.87

0.77

300

0.983

0.92

0.85

0.72

500

0.979

0.90

0.81

0.66

1000

0.971

0.86

0.74

0.55

The effect of Vitamin C is identified only as one of 4 antioxidants that have a limit imposed on their multiple amounts. See the Global antioxidant model for more on this. Thus for best assured benefits individuals should consume some amounts of each as each antioxidant probably provides a partly different combination of benefits.  This behavior is assumed for effects of the antioxidants on both cardiovascular diseases and cancer.  Thus if adequate antioxidants are provided from other vitamins, minerals, or sources, no added benefit from Vitamin C may be achieved.

Men may develop a somewhat higher benefit for cancer risk from vitamin C than do women  This is noted in Studies A1, A2, and R1. It also is possible that pre-menopausal women may obtain less benefit from antioxidants because of the protective effect of estrogen.   Most diets may average only 200 to 250 mg/day of the vitamin.  Because benefits appear useful up to amounts of about 750 mg/day, the research to date suggests that health-interested persons should consider taking a 500 mg/day supplement of Vitamin C each day. Beyond its potential value in reducing risk of the major diseases, antioxidant vitamins been found to reduce risk of other problems including cataracts, cognitive impairment, arthritis, asthma and macular degeneration.

See other papers of antioxidants and CV disease for Vitamin EVitamin AVitamin C; and Selenium , papers of antioxidants and cancer for Vitamin E Vitamin A; and Selenium, and Antioxidants, Death from All Causes and Antioxidants, a Global Analysis.

                                                                        VITAMIN C and CANCER

 No

Study

Population

M/W

Risk

Ratio

Error

Margin

Amount

Diff

Avg

Yrs

Risk/

year

Notes

BREAST CANCER

B1 Howe GR, J nat Cancer Inst 1990, 82:561 12 case control studies M&W 0.69 p < 0.0001        

B2

Hunter, DJ, N Engl J Med 1993, 329:234

1439 of 89,000 ages 34-59

W

1.03

1.02

0.87-1.21

0.80-1.31

375

11-14

9-12

1.00

Quintiles for 8 years of study

B3 Freudenheim JL, J Natl Cancer Inst 1996, 88:340 297 cases vs 311 controls in NY W 0.98 0.62-1.64 300     Quartiles of amount

B4

Verhooven, DT, Crit J Cancer 1997, 75:149

650 cases of 85,000 in Netherlands Ages 55-69

W

0.77

0.85-1.08

400

9

0.97

Quintiles, heavily adjusted

B5

Moorman, PG. Public Health Nutr 2001, 4:821

861 cases, 791 controls

W

0.79

0.84:1.14

400E

 

 

 

B6 Adzersen KH, Nutr Cancer 2003, 46:131 310 cases vs 353 controls in Germany W 0.49 0.2-0.88 n/a     Amounts of nutrients in blood

 

PROSTATE CANCER

 

 

 

 

 

 

 

P1

Kristal, AR, Cancer Epidemiol Biomarker Prev 1999,  8:887

697 cases vs 666 controls

M

0.77

0.57-1.04

400

7

0.96

Supplement used daily

P2

Denio-Pelligrini, H, Br J Cancer 1999, 80:591

185 cases, 223 control, Uruguay

M

0.4

0.2-0.5

 

 

 

Quartiles of Diet

P3 Kirsh VR, J Natl Cancer Inst 2006, 98:245

1338 prostate cancer cases of 29,400 men, US

         M

0.90

0.76-1.06

560

10+

0.99

supplements

 

 

 

 

 

 

 

 

 

 

 

OVARIAN CANCER

 

 

 

 

 

 

 

O1

Fairfield FM, Cancer 2001, 92:2319

301 events of 80,000 nurses

W

1.01

0.69-1.47

500E

20

1.00

Quartiles of Diet

O2

,Silvera FA, Cancer Epidemiol Biomarkers Prev  2006, 15:395

502 cases from 49,600 in Canada age start 49,

,       W

1.11

 0.75-1.66

280 vs abt 90 mg/day

16.4

 

quartriles of diet and supplements

                   

 

CERVICAL CANCER

 

 

 

 

 

 

,

CE1

Slattery ML, Epidemiology 1990,  1:8

266 cases, 408 controls

W

,0.55

 

300

 

 

Quartiles of Diet

CE2

Atalah E, Rev Med Chil 2001, 129:597

170 cases, 3540 controls

W

0.7

 

 

 

 

 

CE3

Verrault, R, Int J Cnacer 1989, 43:1050

189 cases

229 controls

W

0.50

 

 

 

 

Quartiles of diet

 

 

 

 

 

 

 

 

 

 

  COLORECTAL CANCER              
CO1 Jacobs EJ, Cancer Epidemiol Biomarkers Prev 2001, 10:17

4404 deaths if US population of 712,000

M&W

0.99

0.89

 

0.85-1.15

0.74-10.9

 

200E

7

15

1.00

0.97

< 10 years

>=10 years as cancer deaths

 

 

 

 

 

 

 

 

 

 

 

BLADDER CANCER

 

 

 

 

 

 

 

B1 Bruemmer B, Am J Cardiol 1996, 144:485 282 cases vs. 405 controls in Wash state, US, age 45-65

M&W

0.52

 

0.40

0.29-0.97

 

0.21-0.76

200E

 

500+

10E

 

10E

0.94

 

0.96

quartiles of diet

trend p=0.03

supplements only

B2

Zeegers MP, Br J Cancer 2000, 85:122

569 events vs 3100 cohort

M&W

0.81

0.61-1.07

100E

10E

0.98

Quintiles b lood

                   

 

 

 

 

 

 

 

 

 

 

 

THROAT & ORAL CANCER

 

 

 

 

 

 

 

T1

Negri E, Int J Cancer 2000, 86:122

754 events vs 1775 controls in Italy and Switzerland

M&W

0.63

 

400E

 

 

Quintiles

                   

 

 

 

 

 

 

 

 

 

 

  LUNG CANCER              
L1 Voorips LE, Cancer Epideiol Biomarkers Prev 2000:9:357 939cases from 58,000 in Netherlands age 55-69 at start M 0.64 0.54-0.77 138 mg vs 51 mg in diet 6.5    
L2 Cho, E, Int J Cancer 2006, 118:970 Pooled analysis of 8 primarty studies M&W 0.80 0.70-0.91   6-16   Multivariate anaysis, diff larger agepajusted
                   
  GASTRIC CANCER              
G1

Botterweck AA, Cancer 2000, 88:737

282 cases of 3123   subcohort of 128,000 in Netherlands

    M&W

  0.70

0.5-1.0

p=0.06

 

6.3

 

Food frequencey by tertiles, heavily adjusted comparison

G2 Lunet N, Nutr Cancer 2006,55:71 233 cases, 321 controls in Portugal

         M&W

0.85 0.45-1.60       Tertiles of Vit C
G3 Jenab M, Carcinogenesis, 2006, 11.2250

215 Cases and 410 controls form 10 European counties Age 59 av

      M&W

      M&W

0.55

 

0.85

0.35-0.97

 

0.53-1.38

Quartiles of blood Vit C

 Diet Vit C

 90 vs 310 mmol/l blood

 

73 to abt 180 mg/day

                   
  STOMACH CANCER            
 

S1

Jacombs EJ, Cancer Epidemiol Biomarkers Prev 2002, 11:35

1725 cases from large population of 1,045,000 in CPS-2 study

  M&W

0.83 0.68-1.01 general use of suplements 16   claimed lesser effect after 10 years use
                   
       ALL CANCER
A-1 Enstrom JF, Epidemiology 1992, 3:194

1800 deaths from 11,300 US adults, 1971-1983

        M

        F

0.78

0.86

0.50-1.17

0.55-1.27

Diet and Supplements

 

 

 

A2 Loria Cm, Am J clin Nutr 2000, 72:139 NHanes on US Population, 500 CVD deaths of 7,000 population

 

M

W

0.49

0.83

0.31-0.76

0.51-1.35

Values in

90 vs 18

97vs23

blood mmol/l

14

 

Est 900 vs 120 mg/day in Vitamin C equiv diet + supplements

                   
  RANDOMIZED CLINICAL TRIALS          
R1 Hercberg S. Arch Intern Med 2004, 164:2335

265 deaths in control group and 295 placebo of 13,000 in France study

         M

         W

0.69

1.04

0.53-0.91

0.85-1.29

120 mg Vit C, 30 mg Vit E, 6 mg beta C, 100 mg Selenium,20 mg zince

7.5

 

 for men    p=0.008

 for women

                   

     

A formula for estimating risk of cancer from use of Vitamin C"

 

amt is amount of Vitamin C in mg

yrs is duration of use of Vitamin C

 

Risk ratio =  exp( -0.00094 * yrs * amt^0.5 )